UCSF Dermatology Grand Rounds and Patient Viewing

ZOOM

October 22, 2025
Grand Rounds and Patient Cases
ZOOM
 

Chilblains and Type I Interferons During the Pandemic:

Who Lives, Who Dies, Who Tells the Story

Lisa Arkin, MD

Director of Pediatric Dermatology; Associate Professor of Dermatology & Pediatrics

University of Wisconsin School of Medicine and Public Health

Learning Objectives:

1. Elucidate the shared immunologic mechanisms that underscore both

disease severity and resilience to SARS-CoV-2 infection

2. Review the story of pandemic-associated chilblains and their relationship

to SARS-CoV-2 infection

3. Speculate on the relationship with cold

Lisa Arkin, MD has the following disclosures:  Grants: PI for Eli Lily, Amgen, Incyte (funds to the institution); Previous research funded by ICTR UW, UW SDRC, Wisconsin Partnership Program, Dermatology Research Foundation, PeDRA, Society for Pediatric Dermatology, NIH Intramural Funding, Sturge Weber Foundation; Consulting: Eli Lily Merck, Sanofi/Regeneron; Organizational leadership: Director of Pediatric Dermatology, UW Health; Senior Leadership Team, UW Dermatology;   Editorial: Reviewer for JAAD, JAMA Derm, Pediatrics, Pediatric Dermatology, and Journal of Human Immunity